End-of-day quote
Other stock markets
|
||
- EUR | - |
07/05 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
06/05 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
Business Summary
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Manufactured Product
90.5
%
| 364,596 | 91.5 % | 400,372 | 90.5 % | +9.81% |
Technology
9.5
%
| 33,775 | 8.5 % | 41,860 | 9.5 % | +23.94% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
38.9
%
| 139,852 | 35.1 % | 172,242 | 38.9 % | +23.16% |
Japan
34.7
%
| 154,636 | 38.8 % | 153,462 | 34.7 % | -0.76% |
Europe
14.9
%
| 62,251 | 15.6 % | 65,745 | 14.9 % | +5.61% |
Asia
10.1
%
| 37,368 | 9.4 % | 44,759 | 10.1 % | +19.78% |
Americas
1.1
%
| 4,053 | 1.0 % | 5,054 | 1.1 % | +24.70% |
Other
0.2
%
| 210 | 0.1 % | 972 | 0.2 % | +362.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 01/86/01 | |
Masashi Miyamoto
PSD | President | 64 | 01/85/01 |
Chief Tech/Sci/R&D Officer | 62 | 01/10/01 | |
Yoshifumi Torii
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/94/01 |
Yutaka Osawa
CMP | Compliance Officer | 64 | 01/84/01 |
Takuo Hirose
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/18/01 |
Director/Board Member | 66 | 01/08/01 | |
Keiji Kuwata
AUD | Comptroller/Controller/Auditor | 61 | 01/19/01 |
Hiroshi Komatsu
AUD | Comptroller/Controller/Auditor | 61 | 01/12/01 |
Wataru Murata
HRO | Human Resources Officer | - | 01/83/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Takashi Oyamada
BRD | Director/Board Member | 68 | 01/21/01 |
Yoshihisa Suzuki
BRD | Director/Board Member | 68 | 01/22/01 |
Director/Board Member | 66 | 01/08/01 | |
Jun Arai
BRD | Director/Board Member | 65 | 01/21/01 |
Masashi Miyamoto
PSD | President | 64 | 01/85/01 |
Yutaka Osawa
CMP | Compliance Officer | 64 | 01/84/01 |
Akira Morita
BRD | Director/Board Member | 73 | 01/19/01 |
Yuko Haga
BRD | Director/Board Member | 68 | 01/19/01 |
Rumiko Nakata
BRD | Director/Board Member | 68 | 01/23/01 |
Chief Tech/Sci/R&D Officer | 62 | 01/10/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 540,000,000 | 247,790,788 ( 45.89 %) | 4,955,614 ( 0.9177 %) | 45.89 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KYOWA KIRIN CO. LTD. 1.29% | 6,986,280 | 1.29% | 117,603,405 $ |
ARDELYX, INC. 1.23% | 2,873,563 | 1.23% | 18,132,183 $ |
52,000 | 0.21% | 283,189 $ |
Company contact information
Kyowa Kirin Co., Ltd.
Otemachi Financial City Grand Cube 1-9-2 Otemachi
100-0004, Tokyo
+81 3 5205 7200
http://www.kyowa-kirin.co.jpSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+15.09% | 78.37B | |
-12.85% | 5.06B | |
+54.35% | 4.85B | |
+16.88% | 2.37B | |
-20.85% | 2.36B | |
+24.62% | 2.27B | |
-29.25% | 2.22B | |
-0.50% | 1.64B | |
-0.69% | 1.58B |
- Stock Market
- Equities
- 4151 Stock
- Stock
- Company Kyowa Hakko Kirin Co Ltd